CERRI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 1.047
EU - Europa 745
AS - Asia 345
SA - Sud America 58
AF - Africa 13
OC - Oceania 5
Totale 2.213
Nazione #
US - Stati Uniti d'America 1.036
IE - Irlanda 264
CN - Cina 206
RU - Federazione Russa 135
SG - Singapore 74
FI - Finlandia 73
DE - Germania 72
IT - Italia 71
BR - Brasile 52
UA - Ucraina 36
HK - Hong Kong 33
CZ - Repubblica Ceca 18
GB - Regno Unito 18
FR - Francia 13
SE - Svezia 13
CA - Canada 10
AT - Austria 6
BE - Belgio 6
IN - India 5
JP - Giappone 5
MA - Marocco 5
MU - Mauritius 5
NL - Olanda 5
AU - Australia 4
AZ - Azerbaigian 2
CH - Svizzera 2
CO - Colombia 2
EG - Egitto 2
ES - Italia 2
IQ - Iraq 2
LK - Sri Lanka 2
OM - Oman 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CL - Cile 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
LT - Lituania 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
TJ - Tagikistan 1
TR - Turchia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 2.213
Città #
Chandler 289
Dublin 264
Ashburn 99
Boardman 58
Helsinki 54
Jacksonville 45
Princeton 45
Lawrence 44
Singapore 38
Shanghai 36
Medford 33
Hong Kong 32
Wilmington 30
Beijing 28
New York 24
Nanjing 23
Moscow 17
Brno 16
Chicago 16
Nanchang 14
Milan 13
Shenyang 13
Changsha 12
Los Angeles 12
Washington 12
Pavia 11
Hebei 10
Rome 10
São Paulo 10
Fairfield 9
Hangzhou 8
Jiaxing 8
Tianjin 8
Düsseldorf 7
Munich 7
Brussels 6
Dallas 6
Norwalk 6
Toronto 6
Tokyo 5
Falls Church 4
Giessen 4
Ningbo 4
Nuremberg 4
Piscataway 4
Woodbridge 4
Xi'an 3
Ann Arbor 2
Baku 2
Bratislava 2
Cairo 2
Colombo 2
Des Moines 2
Falkenstein 2
Guarulhos 2
Kunming 2
London 2
Mogi das Cruzes 2
Naples 2
Osio Sotto 2
Ostiglia 2
Ottawa 2
Prague 2
Rio de Janeiro 2
Salford 2
Santa Clara 2
Seattle 2
Shijiazhuang 2
Southend 2
Treviso 2
Turin 2
Verona 2
Vienna 2
Wayland 2
Wuhan 2
Zhengzhou 2
Zurich 2
Agudos 1
Almenara 1
Almere Stad 1
Ambrolauri 1
Araraquara 1
Araçatuba 1
Asunción 1
Atlanta 1
Auckland 1
Bandar Seri Begawan 1
Basra 1
Belo Horizonte 1
Berlin 1
Bishkek 1
Bogotá 1
Borås 1
Brasília 1
Buffalo 1
Böblingen 1
Campinas 1
Campo do Meio 1
Canberra 1
Canoas 1
Totale 1.494
Nome #
Immediate early genes regulation in rat cerebellar cortex during long-term synaptic plasticity induction. 86
Postnatal development of Central Nervous System: anomalies in the formation of cerebellum fissures 78
Interaction between the cellular prion (PrPC) and the 2P domain K+ channel TREK-1 protein. 78
Activation of the CREB/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer 74
Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: Relevance to gastrointestinal dysfunctions in Parkinson's disease 72
Effects of cisplatin on neuronal cell B50: involvement of mitochondria in apoptosis induction. 71
Developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum 70
Cell proliferation and death in the brain of active and hibernating frogs 69
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 67
The insect brain as a model to investigate the PCB effects. Changes of NOS-dependent NADPH diaphorase activity in Blattella germanica 66
Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease 62
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease 60
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease 55
Gba mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with parkinson’s disease 55
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 53
Inefficient DNA Repair Is an Aging-Related Modifier of Parkinson's Disease 53
Interactions of neurotransmitter systems during postnatal development of the rat hippocampal formation: effects of cisplatin 52
Radiological analysis of gastrointestinal dysmotility in a model of central nervous dopaminergic degeneration: Comparative study with conventional in vivo techniques in the rat 51
In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease 50
A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease 50
An update on the use of non-ergot dopamine agonists for the treatment of Parkinson’s disease 50
Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat 47
Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity 47
Repurposing opportunities for Parkinson’s disease therapies 47
Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease 47
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 46
Potential therapeutic effects of polyphenols in Parkinson's disease: In vivo and in vitro pre-clinical studies 46
Intracarotid infusion of mesenchymal stem cells in an animal model of Parkinson’s disease, focusing on cell distribution and neuroprotective and behavioral effects 46
Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson's disease 46
Neuroprotective effects of lignan 7-hydroxymatairesinol (HMR/lignan) in a rodent model of Parkinson's disease 45
The exosomal/total α-synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients 42
Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration 40
Mitochondrial Complex i Reversible S-Nitrosation Improves Bioenergetics and Is Protective in Parkinson's Disease 40
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease 40
Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine 39
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease 39
Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: Implications for reparative therapy in Parkinson's disease 38
Dual target strategy: Combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l -DOPA-induced rotational behavior in a rodent model of Parkinson's disease 37
Parkinson's Disease in Women and Men: What's the Difference? 31
Investigational drugs in Phase I and Phase II for Levodopa-induced dyskinesias 29
Profiling the Biochemical Signature of GBA-Related Parkinson's Disease in Peripheral Blood Mononuclear Cells 25
Peripheral-central neuroimmune crosstalk in parkinson’s disease: What do patients and animal models tell us? 24
Impaired Mitochondrial Respiration in REM-Sleep Behavior Disorder: A Biomarker of Parkinson's Disease? 23
Role of autophagy in Parkinson’s disease 21
In vivo modeling of prodromal stage of Parkinson's disease 19
Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease 17
Parkinson’s disease 16
Investigation and Comparison of Active and Passive Encapsulation Methods for Loading Proteins into Liposomes 14
Totale 2.273
Categoria #
all - tutte 12.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.513


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202049 0 0 0 0 0 0 0 0 0 15 34 0
2020/2021107 8 7 2 6 0 11 0 21 23 16 9 4
2021/2022189 0 1 3 0 1 5 2 11 10 0 33 123
2022/2023757 91 80 15 55 58 62 0 41 328 3 17 7
2023/2024362 54 50 14 15 27 96 20 22 6 14 28 16
2024/2025595 48 64 28 21 21 60 42 53 210 48 0 0
Totale 2.273